These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 19221354)

  • 1. Antimicrobial resistance in hospitals: how concerned should we be?
    Mulvey MR; Simor AE
    CMAJ; 2009 Feb; 180(4):408-15. PubMed ID: 19221354
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimicrobial use in hospitals: managing a medical treasure.
    Gaynes R
    MedGenMed; 2007 Nov; 9(4):32. PubMed ID: 18311382
    [No Abstract]   [Full Text] [Related]  

  • 3. Modeling antibiotic resistance in hospitals: the impact of minimizing treatment duration.
    D'Agata EM; Magal P; Olivier D; Ruan S; Webb GF
    J Theor Biol; 2007 Dec; 249(3):487-99. PubMed ID: 17905310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals.
    Gaynes R
    Infect Dis Clin North Am; 1997 Dec; 11(4):757-65. PubMed ID: 9421698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mathematical models for the evaluation of antibiotic resistance in hospitals: a systematic review.
    Bonovas S; Panagiotakos DB; Charalambides Ch; Vatopoulos A
    Cent Eur J Public Health; 2003 Dec; 11(4):229-37. PubMed ID: 14768788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for improving antimicrobial use and the role of antimicrobial stewardship programs.
    File TM; Solomkin JS; Cosgrove SE
    Clin Infect Dis; 2011 Aug; 53 Suppl 1():S15-22. PubMed ID: 21795724
    [No Abstract]   [Full Text] [Related]  

  • 7. Modeling antimicrobial cycling and mixing: Differences arising from an individual-based versus a population-based perspective.
    Uecker H; Bonhoeffer S
    Math Biosci; 2017 Dec; 294():85-91. PubMed ID: 28962827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibiotic pressure and bacterial resistance in the hospital].
    Bergogne-Bérézin E
    Presse Med; 1998 Jun; 27 Suppl 3():5-14. PubMed ID: 9767766
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibiotic resistance: the pandemic.
    Verhoef J
    Adv Exp Med Biol; 2003; 531():301-13. PubMed ID: 12916802
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibiotic resistance: how serious is the problem, and what can be done?
    Hooper DC; DeMaria A; Limbago BM; O'Brien TF; McCaughey B
    Clin Chem; 2012 Aug; 58(8):1182-6. PubMed ID: 22634378
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical significance of the emergence of bacterial resistance in the hospital environment.
    Hosein IK; Hill DW; Jenkins LE; Magee JT
    J Appl Microbiol; 2002; 92 Suppl():90S-7S. PubMed ID: 12000618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial stewardship programs in community hospitals: the evidence base and case studies.
    Ohl CA; Dodds Ashley ES
    Clin Infect Dis; 2011 Aug; 53 Suppl 1():S23-8; quiz S29-30. PubMed ID: 21795725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successful strategies against increasing antibiotic resistance].
    Sax H
    Ther Umsch; 2002 Jan; 59(1):51-5. PubMed ID: 11851049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calculated and controlled pharmacotherapy of problem infections in intensive care patients].
    Breithaupt H
    Zentralbl Chir; 1996; 121 Suppl():37-8. PubMed ID: 8967233
    [No Abstract]   [Full Text] [Related]  

  • 15. [Extended spectrum beta lactamase forming pathogens (ESBL)].
    Gastmeier P
    Med Klin Intensivmed Notfmed; 2012 Nov; 107(8):592-3. PubMed ID: 23138656
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimicrobial resistance in internal medicine wards.
    Menichetti F; Tagliaferri E
    Intern Emerg Med; 2012 Oct; 7 Suppl 3():S271-81. PubMed ID: 23073868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Need and potential of antimicrobial stewardship in community hospitals.
    Septimus EJ; Owens RC
    Clin Infect Dis; 2011 Aug; 53 Suppl 1():S8-S14. PubMed ID: 21795728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Empirical antibiotic therapy: arguments in favour of the monotherapy].
    Dupont H
    Ann Fr Anesth Reanim; 2004 Jun; 23(6):631-5. PubMed ID: 15234733
    [No Abstract]   [Full Text] [Related]  

  • 19. Preventing bacterial resistance in surgical patients.
    Evans HL; Sawyer RG
    Surg Clin North Am; 2009 Apr; 89(2):501-19, x. PubMed ID: 19281897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluopsin C: a potential candidate against the deadly drug-resistant microbial infections in humans.
    Sharma D
    Future Microbiol; 2020 Apr; 15():381-384. PubMed ID: 32242758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.